Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 
Home > Public > Tissue Bank / Translational Research

Tissue Bank / Translational Research 

IBCSG Tissue Bank

The IBCSG Tissue Bank contains formalin-fixed, paraffin-embedded (FFPE) primary breast cancer specimens, from almost 10,000 patients included in clinical trials conducted by the Group since 1981. The specimens are used for Central Pathology Review by the reference pathologist appointed for the trial, and for translational research specified in the trial protocol or proposed by qualified investigators. This highly valued material is available for correlative studies that relate markers to clinical outcomes documented during the conduct and follow-up of our clinical trials – research that improves our understanding of the prevention, diagnosis and treatment of breast cancer.

IBCSG Tissue Bank Policy (English)
IBCSG Tissue Bank Policy (French)
IBCSG Tissue Bank Policy (German)

Availability of material in IBCSG Tissue Bank

 

Biological Protocol Working Group (BPWG)

Researchers may submit sound scientific proposals for the use of the FFPE tissue. The Biological Protocol Working Group (BPWG), a panel of experts, ensures that the proposals address fundamental and relevant biological questions. Details for submitting project proposals and a template for the application can be downloaded under ‘Research’, Application for Project Grant.

BPWG Policies and Procedures

Central Pathology Office (CPO)

Information concerning submission and shipment of pathology materials can be found under the Central Pathology Office section. The IBCSG PCO is responsible for the collection, tracking, banking, and dissemination of all FFPE pathology material. All of this, and ultimately also research using the tissue, is done under strict observation of patients’ rights and confidentiality.

News

23.03.2019:
The next IBCSG Annual Meeting will take place in Vienna Austria on March 23 and 24, 2019.       

20.03.2019:
16th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer

09.10.2018:
Clinical Trials

All News


 
  Print